Argenx is seeking a Clinical Development Asset Lead for their innovative research in autoimmune diseases, particularly focusing on neuromuscular disorders. The ideal candidate will have a strong background in clinical development, leadership experience, and a medical degree, particularly in neurology
Job Summary
Adimanebart (ARGX-119) is a novel anti-MuSK agonist monoclonal antibody being developed for neuromuscular diseases including CMS, ALS, and SMA.
The role involves delivering strategic clinical development leadership and oversight as part of the Asset Strategy Team to maximize asset value.
The ideal candidate will have significant experience in clinical development for neurologic disorders and a proven track record in drug development.
Matching Summary
Match Score: 85
Argenx is seeking a Clinical Development Asset Lead for their innovative research in autoimmune diseases, particularly focusing on neuromuscular disorders. The ideal candidate will have a strong background in clinical development, leadership experience, and a medical degree, particularly in neurology.
Salary
$296,000.00 - $407,000.00 USD
Skills & Requirements
Must-have
neurology specialty education
global drug development expertise
clinical development leadership
cross-functional collaboration
academic medical center collaboration
Nice-to-have
science-based start-up environment
inspiring and growing company culture
delivering medicines for patients
Key Requirements
Medical Doctor; neurology specialty education required